Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01098942 · ClinicalTrials.gov registry record
Bariatric Surgery and Skeletal Health
A clinical trial, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- 50
- Enrollment target
NCT01098942: Completed study, sponsored by Massachusetts General Hospital.
NCT01098942 is a clinical trial that has completed, run by Massachusetts General Hospital. The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01098942 has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
Study Summary
Bone loss may occur after bariatric (weight loss) surgery, but standard methods of measuring bone density in obese patients are potentially inaccurate. This study uses quantitative computed tomography to examine changes in bone mineral density after bariatric surgery. We are also studying mechanisms which may explain bone loss after bariatric surgery.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2009-11 |
| Est. Completion | 2018-03 |
What the finished NCT01098942 record still lists
NCT01098942 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01098942 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01098942 about?
NCT01098942 is a clinical study titled "Bariatric Surgery and Skeletal Health". Bone loss may occur after bariatric (weight loss) surgery, but standard methods of measuring bone density in obese patients are potentially inaccurate. This study uses quantitative computed tomography to examine changes in bone mineral density after bariatric surgery. We are also studying mechanisms...
What is the current status of trial NCT01098942?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2009-11. Estimated completion is 2018-03.
Who is sponsoring clinical trial NCT01098942?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia